$TWST

Green Paula sold $49K of TWST

Green Paula (SVP of Human Resources) sold 294 shares of Twist Bioscience Corp (TWST) at $165.49 on 2026-09-21.

Original reporting
SEC EDGAR · Green Paula
Published Sep 23, 2026, 8:07 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 23, 2026, 8:18 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TWST
Neutral
medium confidence
Mentioned
$TWST
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TWSTNeutralLow
01

Why it matters

Traders may monitor insider activity for sentiment, but this specific transaction is small and lacks any accompanying corporate or operational news.

02

Market read

A disclosed insider open-market sale can slightly pressure sentiment, but it is unlikely to drive price without additional company-specific catalysts.

03

What to watch

No 10b5-1 plan is noted, but the filing does not provide motive, tax context, or whether other insiders are buying or selling around the same period.

Relevance 3/10Novelty 4/10Timing: Filed 2026-09-23, sale executed 2026-09-21.

Background

The article is an SEC Form 4 insider transaction disclosure for Twist Bioscience.

Company-level read

Ticker impact

$TWSTNeutralMedium confidence
Context

Form 4 shows SVP of Human Resources Green Paula sold 294 shares of Twist Bioscience at $165.4910 on 2026-09-21, totaling $48,654.35.

Expected impact

Likely limited, short-lived sentiment impact; no clear directional signal from this small transaction size.

Evidence & confidence

The disclosure is an insider sale (not a buy), but the dollar value is relatively small and there is no stated company-specific event or guidance change in the filing.

Market effects

Minimal. Insider sale does not indicate sector-wide change.

None.

None.

Counterpoint

The sale may be for personal liquidity needs and does not necessarily reflect negative views on Twist Bioscience fundamentals.

Key entities

  • Twist Bioscience Corp

    US-listed biotech company subject of the Form 4 insider sale disclosure.

  • Green Paula

    SVP of Human Resources who sold 294 shares on 2026-09-21.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TWSTHigh

Twist Bioscience TWST Stock Jumps On AI Drug Discovery Deals

Twist Bioscience (TWST) stock rose 10.19% after announcing AI drug discovery deals with Eli Lilly's TuneLab. The company reported $118.4M in quarterly revenue, a $35.1M net loss, and positive operating cash flow of $1.1M. Analysts have raised price targets, with Guggenheim setting it at $212. TWST is seen as a key player in AI-driven biotech.

$TWSTMed

Twist Bioscience Stock Jumps As Lilly AI Deal Fuels Bullish Target Hike

Twist Bioscience (TWST) stock rose 16.21% after announcing a partnership with Eli Lilly's AI drug discovery platform, TuneLab. The company reported Q3 revenue of $118.4M, with a gross margin of 52% but a net loss of $35.1M. Leerink raised its price target to $160, citing the AI-driven opportunity. TWST is trading at a high valuation with a price-to-sales ratio over 25.

$TWSTMed

Twist Bioscience Stock Jumps As AI Deals Fuel Bullish Target Hike

Twist Bioscience (TWST) stock rose 8.35% on September 24, 2026, driven by its AI partnership with Eli Lilly's TuneLab platform. The company's stock has seen significant gains recently, trading at $171.74 from $139 over a few weeks. TWST reported quarterly revenue of $118.38M, with a net loss of $35.05M. Leerink raised its price target to $160, citing AI drug discovery opportunities.